Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. The Company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
Type | Private | |
Founded | 2018 | |
HQ | Atlanta, GA, US | Map |
Website | antiostherapeutics.com |
Employees (est.) (Mar 2021) | 13 | (+19%) |
Cybersecurity rating | A | More |
Founding Date | 2018 |
Antios Therapeutics total Funding | $25 m |
Antios Therapeutics latest funding size | $25 m |
Time since last funding | 2 years ago |
Antios Therapeutics investors | Fonds de solidarité FTQ, Domain Associates, Georgia Research Alliance, CAM Capital, Lumira Ventures |
When was Antios Therapeutics founded?
Antios Therapeutics was founded in 2018.
How many employees does Antios Therapeutics have?
Antios Therapeutics has 13 employees.
Who are Antios Therapeutics competitors?
Competitors of Antios Therapeutics include Vitality Biopharma, Opiant Pharmaceuticals and IntelGenx.
Where is Antios Therapeutics headquarters?
Antios Therapeutics headquarters is located at P.O. Box 12260, Atlanta.
Where are Antios Therapeutics offices?
Antios Therapeutics has an office in Atlanta.
How many offices does Antios Therapeutics have?
Antios Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies